The impact of a 6-year comprehensive community trial on the awareness, treatment and control rates of hypertension in Iran: Experiences from the Isfahan healthy heart program

BMC Cardiovascular Disorders

Volumn 10, Issue , 2010, Pages

  Khosravi, Alireza ^a   Mehr, Gilda K ^a   Kelishadi, Roya ^a   Shirani, Shahin ^a   Gharipour, Mojgan ^a   Tavassoli, Aliakbar ^a,b   Noori, Fatemeh ^a   Sarrafzadegan, Nizal ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; COMMUNITY CARE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERTENSION; INTERVENTION STUDY; IRAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SYSTOLIC BLOOD PRESSURE; URBAN AREA; ATTITUDE TO HEALTH; TIME;

ADULT; COMMUNITY HEALTH SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; IRAN; MALE; TIME FACTORS;

EID: 78650293092     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-10-61     Document Type: Article

References (25)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-23.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360(9349):1903-13. 10.1016/S0140-6736(02)11911-8, 12493255.
3. Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002, 360(9343):1347-60. 10.1016/S0140-6736(02)11403-6, 12423980.
4. Chockalingam A, Campbell NR, Fodor JG. Worldwide epidemic of hypertension. Can J Cardiol 2006, 22(7):553-5. 2560860, 16755308.
5. Cheung BM, Ong KL, Man YB, Lam KS, Lau CP. Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich) 2006, 8(2):93-8. 10.1111/j.1524-6175.2006.04895.x, 16470077.
6. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289(18):2363-9. 10.1001/jama.289.18.2363, 12746359.
7. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. Prevalence, awareness, treatment and control of hypertension in China. Hypertension 2002, 40(6):920-7. 10.1161/01.HYP.0000040263.94619.D5, 12468580.
8. Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens 2006, 24(8):1515-21. 10.1097/01.hjh.0000239286.02389.0f, 16877953.
9. Khosravi A, Pourmoghaddas M, Kelishadi R, Sabet B, Ansari R, Shirani S, et al. Trend in hypertension level, prevalance of hypertension and its care in Isfahan. MJIRC 2005, 8(2):62-8.
10. Sarraf-Zadegan N, Sadri G, Malek AH, Baghaei M, Mohammadi FN, Shahrokhi S, et al. Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol 2003, 58(4):309-20. 10.2143/AC.58.4.2005288, 12948036.
11. Sarrafzadegan N, Baghaei A, Sadri G, Kelishadi R, Malekafzali H, Boshtam M, et al. Isfahan healthy heart program: Evaluation of comprehensive, community-based interventions for non-communicable disease prevention. Prevention and Control 2006, 2:73-84.
12. Grossman E, Messerli FH. Hypertension and diabetes. Adv Cardiol 2008, 45:82-106. full_text, 18230957.
13. Shirani S, Kelishadi R, Sarrafzadegan N, Khosravi A, Sadri G, Amani S, Heidari S, Ramezani MA. Awareness, treatment and control of hypertension, duslipidemia and diabetes mellitus in an Iranian population. East Med Health J 2009, 15(6):1474-1483.
14. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290(2):199-206. 10.1001/jama.290.2.199, 12851274.
15. Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 1995, 18(3):181-96. 10.1291/hypres.18.181, 7584927.
16. Nissinen A, Tuomilehto J, Elo J, Alasoini A, Varvikko P, Puska P. North Karelia (Finland) hypertension detection project. Five-year follow-up of hypertensive cohort. Hypertension 1983, 5(4):564-72.
17. Cheung BM, Ong KL, Man YB, Lam KS, Lau CP. Prevalence, awareness, treatment, and control of hypertension: United States National Health and Nutrition Examination Survey 2001-2002. J Clin Hypertens (Greenwich) 2006, 8(2):93-8. 10.1111/j.1524-6175.2006.04895.x, 16470077.
18. Maldonado J. Blood pressure screening, management and control in England: results from the Health Survey for England 1994. Rev Port Cardiol 1999, 18(10):959-60.
19. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997, 10(10 Pt 1):1097-102. 10.1016/S0895-7061(97)00224-0, 9370379.
20. Vargas CM, Ingram DD, Gillum RF. Incidence of hypertension and educational attainment: the NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol 2000, 152(3):272-8. 10.1093/aje/152.3.272, 10933274.
21. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001, 345(7):479-86. 10.1056/NEJMoa010273, 11519501.
22. Barker WH, Mullooly JP, Linton KL. Trends in hypertension prevalence, treatment, and control: in a well-defined older population. Hypertension 1998, 31(1 Pt 2):552-9.
23. Tesfaye F, Nawi NG, Van MH, Byass P, Berhane Y, Bonita R, et al. Association between body mass index and blood pressure across three populations in Africa and Asia. J Hum Hypertens 2007, 21(1):28-37. 10.1038/sj.jhh.1002104, 17066088.
24. Njelekela M, Negishi H, Nara Y, Tomohiro M, Kuga S, Noguchi T, et al. Cardiovascular risk factors in Tanzania: a revisit. Acta Trop 2001, 79(3):231-9. 10.1016/S0001-706X(01)00134-6, 11412807.
25. Kadiri S, Walker O, Salako BL, Akinkugbe O. Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens 1999, 13(1):23-7. 10.1038/sj.jhh.1000722, 9928748.